Basile, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 1.817
EU - Europa 1.420
AS - Asia 586
OC - Oceania 15
SA - Sud America 14
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.862
Nazione #
US - Stati Uniti d'America 1.799
SE - Svezia 456
IT - Italia 278
CN - Cina 218
SG - Singapore 205
DE - Germania 144
IE - Irlanda 120
PL - Polonia 104
FR - Francia 73
ID - Indonesia 70
GB - Regno Unito 50
RU - Federazione Russa 48
FI - Finlandia 43
IN - India 36
UA - Ucraina 27
BE - Belgio 18
CA - Canada 16
TR - Turchia 13
CZ - Repubblica Ceca 10
NL - Olanda 10
AU - Australia 9
BR - Brasile 9
HK - Hong Kong 9
ES - Italia 8
CI - Costa d'Avorio 7
IR - Iran 7
JP - Giappone 6
NZ - Nuova Zelanda 6
LT - Lituania 5
VN - Vietnam 5
BY - Bielorussia 4
DK - Danimarca 4
KR - Corea 4
PT - Portogallo 4
CH - Svizzera 3
CL - Cile 3
KZ - Kazakistan 3
RO - Romania 3
GR - Grecia 2
HU - Ungheria 2
MX - Messico 2
PH - Filippine 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
EU - Europa 1
IL - Israele 1
KH - Cambogia 1
MC - Monaco 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NP - Nepal 1
PY - Paraguay 1
Totale 3.862
Città #
Chandler 492
Ashburn 204
Singapore 167
Dublin 119
Warsaw 104
New York 99
Jakarta 70
San Mateo 62
Rome 55
Fairfield 52
Wilmington 45
Marseille 42
Princeton 42
Boston 39
Moscow 37
Milan 35
Ann Arbor 30
Helsinki 30
Nanjing 30
Cattolica 28
Jacksonville 28
Boardman 27
Beijing 25
Seattle 24
Woodbridge 22
Bremen 21
Dearborn 21
Houston 20
Redwood City 20
Munich 17
Brussels 15
Bologna 14
Castelnuovo di Val di Cecina 14
Falls Church 14
Los Angeles 13
Hebei 12
Norwalk 12
Edinburgh 10
Shenyang 10
Tianjin 10
Atlanta 9
Cambridge 9
London 9
Nanchang 9
Brno 8
Hong Kong 8
Lancaster 8
Leawood 8
Abidjan 7
Augusta 7
Izmir 7
Toronto 7
Chicago 6
Jiaxing 6
Lappeenranta 6
Lawrence 6
Paris 6
Redmond 6
Auckland 5
Berlin 5
Kunming 5
Palermo 5
Pune 5
São Paulo 5
Washington 5
Amsterdam 4
Esslingen am Neckar 4
Frankfurt am Main 4
Guangzhou 4
Hangzhou 4
Hounslow 4
Jinan 4
Kish 4
Lanzhou 4
Melbourne 4
Minsk 4
Nürnberg 4
Ottawa 4
Shanghai 4
Brisbane 3
Busan 3
Busto Arsizio 3
Changsha 3
Codroipo 3
Dallas 3
Hanoi 3
Muravera 3
Novato 3
Nuremberg 3
Priverno 3
San Diego 3
San Jose 3
Tokyo 3
Afyonkarahisar 2
Alatri 2
Almaty 2
Baotou 2
Bari 2
Ben Arous 2
Bern 2
Totale 2.410
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 285
Overview of immune abnormalities in lysosomal storage disorders 103
Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses 99
Evaluation of screening method for Bence Jones protein analysis 96
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 94
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 90
Comparison between the traditional and a rapid screening test for cryoimmunoglobulins detection 84
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 83
Immunological role of IgG subclasses 83
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 79
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 79
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 78
Pre-analytical phase in cryoglobulin (CRG) detection: an alternative method for sample transport 77
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 76
Immunological role of IgG subclasses 75
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 73
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 71
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 70
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 68
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 68
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 67
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 66
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 66
The Laboratory Role in anti-TNF Biological Therapy Era 65
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 65
Anti-nuclear antibody detection in cryoprecipitates: Distinctive patterns in hepatitis C virus-infected patients 64
Heavy chain disease: Our experience 63
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 63
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 62
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 62
IgG cryoglobulinemia 60
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 59
Cryoglobulins: putative effectors of adaptive immune response 59
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 58
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 58
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 58
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 57
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 56
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 55
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 54
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 53
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 52
Free light chains and autoimmunity 52
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 51
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 49
COVID-19, adaptative immune response and metabolic-associated liver disease 49
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 46
Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy 39
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 37
Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity 36
Serum free light chain quantitative assays: Dilemma of a biomarker 36
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 35
Antenna-enhanced mid-infrared detection of extracellular vesicles derived from human cancer cell cultures 33
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 33
SARS-CoV-2 was already circulating in Italy, in early December 2019 31
The dark side of current analytic methods for Bence Jones Proteinuria 30
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 28
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 28
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 27
Sensing red blood cell nano-mechanics: Toward a novel blood biomarker for Alzheimer’s disease 24
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 23
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 22
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 19
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 18
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 18
Type 2 cytokines and scleroderma interstitial lung disease 15
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 14
SCREENING FOR THE IDENTIFICATION OF AUTOIMMUNE OR LYMPHOPROLIFERATIVE ONSET IN PATIENTS NAiVE TO HCV ANTIVIRAL TREATMENT 14
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 13
Calprotectin: two sides of the same coin 10
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 9
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand? 6
Totale 3.998
Categoria #
all - tutte 21.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.021


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020183 0 0 0 0 18 29 42 8 11 33 35 7
2020/2021264 26 14 10 9 33 11 8 6 18 17 70 42
2021/2022492 23 11 5 72 38 18 12 76 24 22 80 111
2022/20231.395 204 179 90 212 89 151 84 121 148 20 73 24
2023/2024839 35 194 12 85 26 161 67 34 6 43 72 104
2024/2025436 60 50 118 84 124 0 0 0 0 0 0 0
Totale 3.998